IRMD Fail-to-Deliver

IRadimed Corporation (IRMD) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $1.09B, listed on NASDAQ, employing roughly 166 people, carrying a beta of 0.91 to the broader market. IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. Led by Roger E. Susi, public since 2014-07-16.

No records carrying symbol IRMD appear in the SEC's published NSCC CNS fails-to-deliver data for settlement dates September 26, 2026 through October 14, 2026.

Most recent fail-to-deliver in our records: September 25, 2026.

Frequently asked IRMD fail-to-deliver questions

Has IRMD had any fails-to-deliver recently?
No records carrying symbol IRMD appear in the SEC's published NSCC CNS fails-to-deliver data for settlement dates September 26, 2026 through October 14, 2026. Most recent fail-to-deliver in our records: September 25, 2026. The SEC publishes the first half of each month at the month's end and the second half around the 15th of the next month, so this check covers settlement dates through October 14, 2026.
What does it mean when IRMD is absent from the SEC fails-to-deliver data?
The SEC's files give the aggregate net balance of shares that failed to be delivered in NSCC's Continuous Net Settlement system, by security and settlement date. Since September 16, 2008 a security has a record for every settlement date on which that balance was above zero, and none when it was zero. This check is by symbol, so a fail reported only under a CUSIP or a former symbol is not counted.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Learn how fails-to-deliver is reported and how to read the data →